Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation

v3.19.3.a.u2
Stock-Based Compensation
12 Months Ended
Sep. 30, 2019
Share Based Compensation [Abstract]  
Stock-Based Compensation

Note 10:       Stock-Based Compensation

From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period.

Stock Options

The following table summarizes stock option activity for the years ended September 30, 2019 and 2018:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Intrinsic

Value

 

Outstanding at September 30, 2017

 

 

211,668

 

 

$

13.19

 

 

 

3.47

 

 

$

454,117

 

Granted

 

 

20,000

 

 

 

32.24

 

 

 

9.02

 

 

 

 

 

Outstanding at September 30, 2018

 

 

231,668

 

 

$

14.84

 

 

 

3.04

 

 

$

162,500

 

Exercisable at September 30, 2018

 

 

175,000

 

 

$

11.89

 

 

 

2.08

 

 

$

162,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2018

 

 

231,668

 

 

$

14.84

 

 

 

3.04

 

 

$

162,500

 

Forfeited

 

 

(31,250

)

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

200,418

 

 

$

16.05

 

 

 

2.40

 

 

$

26,750

 

Exercisable at September 30, 2019

 

 

168,084

 

 

$

13.92

 

 

 

1.44

 

 

$

26,750

 

 

The Company recognized compensation expense of $142 and $227 during the years ended September 30, 2019 and 2018, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures. No forfeitures are estimated.

At September 30, 2019 the Company had $145, of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the Company expects will be recognized through December of 2021.

The exercise price for stock options outstanding and exercisable at September 30, 2019 is as follows:

 

Outstanding

 

 

Exercisable

 

Number of

 

 

Exercise

 

 

Number of

 

 

Exercise

 

Options

 

 

Price

 

 

Options

 

 

Price

 

 

25,000

 

 

 

7.50

 

 

 

25,000

 

 

 

7.50

 

 

31,250

 

 

 

10.00

 

 

 

31,250

 

 

 

10.00

 

 

16,668

 

 

 

10.86

 

 

 

8,334

 

 

 

10.86

 

 

6,250

 

 

 

12.50

 

 

 

6,250

 

 

 

12.50

 

 

6,250

 

 

 

15.00

 

 

 

6,250

 

 

 

15.00

 

 

75,000

 

 

 

15.18

 

 

 

75,000

 

 

 

15.18

 

 

8,000

 

 

 

23.41

 

 

 

8,000

 

 

 

23.41

 

 

8,000

 

 

 

27.60

 

 

 

8,000

 

 

 

27.60

 

 

8,000

 

 

 

31.74

 

 

 

 

 

 

 

 

8,000

 

 

 

36.50

 

 

 

 

 

 

 

 

8,000

 

 

 

41.98

 

 

 

 

 

 

 

 

200,418

 

 

 

 

 

 

 

168,084

 

 

 

 

 

 

The following table summarizes information about the Company’s non-vested shares as of September 30, 2019:

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant-Date

 

Non-vested Shares

 

Shares

 

 

Fair Value

 

Non-vested at September 30, 2018

 

 

48,501

 

 

$

25.53

 

Vested

 

 

(12,167

)

 

$

21.87

 

Non-vested at September 30, 2019

 

 

36,334

 

 

$

26.76

 

 

No stock options were granted during the year ended September 30, 2019. For stock options granted during September 30, 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $10.14, and the weighted-average exercise price of such options was $32.24.

The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted during September 30, 2018 are as follows:

 

Risk-free interest rate

 

1.25%

 

Expected life of the options

 

5 and 10 years

 

Expected volatility

 

107%

 

Expected dividend yield

 

0%